Feasibility And Safety Of A Combined Metabolic Strategy In Glioblastoma Multiforme

This study examined whether people with glioblastoma multiforme (GBM), an aggressive type of brain cancer, could safely and effectively combine two metabolic approaches: periodic prolonged fasting and a ketogenic diet. The researchers were interested in this combination because both strategies lower blood glucose and raise ketones, which may help fight this type of cancer that relies heavily on glucose for energy.

Ten patients with GBM followed a protocol where they completed 5-7 day fasts every 1-2 months, combined with a modified ketogenic diet during the weeks between fasts. The researchers tracked their blood glucose and ketone levels using a measurement called the glucose-ketone index (GKI), aiming to keep it below 6, which indicates a strong metabolic shift away from glucose dependence. Patients monitored their own blood levels and body weight throughout the study.

The results showed this combined approach was both feasible and safe. Patients successfully maintained the protocol for an average of about 5 months, completing multiple fasting cycles while staying on the ketogenic diet between fasts. They achieved the target metabolic state, with even better results during fasting periods. The most common side effects were fatigue, irritability, and feeling lightheaded, but these were manageable. Importantly, the metabolic interventions didn't interfere with standard cancer treatments like chemotherapy and radiation.

This research is significant because it's the first study to demonstrate that this intensive metabolic approach can be sustained long-term in cancer patients. While this was a small observational study focused on safety and feasibility rather than cancer outcomes, it provides important groundwork for understanding how metabolic interventions might be integrated into comprehensive cancer care and supports the growing interest in metabolic approaches to health optimization.